Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study. Peltier A, van Velthoven R, Baudewyns A, Assenmacher G, et al. BJU Int 2024 May 14. doi: 10.1111/bju.16385.

Read + Share

Amedeo Smart

Independent Medical Education

Peltier A, van Velthoven R, Baudewyns A, Assenmacher G, et al. Targeted microwave ablation for prostate cancer (FOSTINE1b): a prospective 'ablate-and-resect' study. BJU Int 2024 May 14. doi: 10.1111/bju.16385.
PMID: 38742416